Vertex Pharmaceuticals has announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a combination regimen with ivacaftor for the treatment of people with cystic fibrosis.
Sensitech, a provider of supply chain visibility solutions, will showcase its suite of solutions at the 25th anniversary edition of LogiPharma, held 8-10th April in Lyon, France.
Aelius Biotech, whose laboratory gut model is used to trial new drugs without the need for animal testing has raised £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.
Ray Baldwin, business development manager, Watson-Marlow Fluid Technology Solutions (WMFTS) explains how all single-use is not created equal and how you can tell the difference.
Ethris and Lonza have announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery that offer a promising approach to combat respiratory diseases.
In its largest-ever funding initiative for early-career researchers, the Academy of Medical Sciences is investing £7.6 million to tackle urgent health challenges from Alzheimer’s disease, cancer and obesity to addiction and climate change impacts.
Tecan Group has announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity.
AMSBIO has expanded its biofluid collection and processing capabilities, to now offer a range of customisable human blood biospecimens from both healthy and disease-state donors to support biomedical research.
Honeywell has introduced TrackWise Manufacturing, an artificial intelligence (AI)-assisted, cloud-native platform designed to transform how life sciences companies manage, automate and digitalise operations.
MultiOmic Health and Alloy Therapeutics have announced they have signed a Memorandum of Understanding to jointly discover and develop first-in-class renal tissue-targeting drugs.
